PRNewsWire - Health

AVEO Oncology, an LG Chem company, Announces Three Poster Presentations at ASCO 2025 Annual Meeting
Bold Therapeutics Announces Presentation of Late-Breaking Data on BOLD-100's Unique Ability to Mitigate Oxaliplatin-Induced Peripheral Neuropathy (OIPN)
Redefining Personalization - New Health Plan Research Shows the Future of Member Engagement, Superior Outcomes, and Improved Consumer Experience
Top Duluth Family Dental Practice, Duluth Dental Studio, Introduces Complimentary 3D Intraoral Scans for New Patients